Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance

Topcu S., Tok D., ÇALIŞKAN M. , Özçimen E. E. , Güllü H., Uçkuyu A., ...Daha Fazla

CLINICAL ENDOCRINOLOGY, cilt.65, ss.75-80, 2006 (SCI İndekslerine Giren Dergi) identifier


Background Women with polycystic ovary syndrome (PCOS) are thought to have increased cardiovascular risk. Metformin therapy reduces whole-body insulin resistance (IR) in patients with type-2 diabetes mellitus (DM).